Boothbay Fund Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.9M Buy
453,882
+104,929
+30% +$505K 0.02% 650
2025
Q4
$1.68M Buy
348,953
+48,184
+16% +$233K 0.03% 622
2025
Q3
$1.52M Buy
300,769
+20,769
+7% +$91.8K 0.02% 669
2025
Q2
$1.13M Sell
280,000
-3,722
-1% -$12.1K 0.02% 650
2025
Q1
$775K Buy
283,722
+173,722
+158% +$623K 0.02% 712
2024
Q4
$468K Sell
110,000
-99,955
-48% -$381K 0.01% 907
2024
Q3
$617K Buy
209,955
+157,889
+303% +$503K 0.01% 918
2024
Q2
$181K Buy
+52,066
New +$174K ﹤0.01% 1304
2023
Q1
Sell
-143,493
Closed -$514K 2142
2022
Q4
$514K Buy
+143,493
New +$613K 0.01% 1169

Other funds holding SRTA

Boothbay Fund Management's SRTA Position: Q1 2026 in Review

Boothbay Fund Management increased its Strata Critical Medical Inc (SRTA) stake by 30% in Q1 2026, buying an estimated $505K and bringing the position to 453,882 shares worth $1.9M. The position accounts for 0.02% of the portfolio, ranked #650.

Boothbay Fund Management first reported a position in SRTA in Q4 2022 and has held it in 9 quarters since. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Boothbay Fund Management held 453,882 shares of Strata Critical Medical Inc worth $1.9M as of Q1 2026.
  • Boothbay Fund Management bought 104,929 Strata Critical Medical Inc shares in Q1 2026, an estimated $505K.
  • Strata Critical Medical Inc made up 0.02% of Boothbay Fund Management's portfolio in Q1 2026, its #650 holding.
  • Boothbay Fund Management first reported a position in Strata Critical Medical Inc in Q4 2022 and has held it in 9 quarters since.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.